Arena Trading Surges Ahead of Key FDA Drug Approval Decision:
if !IE-->endif-->Content on this page requires a newer version of Adobe Flash Player.if !IE-->endif-->
SAN DIEGO (TheStreet) -- Arena Pharmaceuticals' share price and trading volume are sharply higher two weeks in front of an expected U.S. approval decision on the company's weight-loss drug.
Ninety minutes into Wednesday trading, more than 23 million shares of Arena have already traded hands with the stock up 7% to $8.42 -- a five-year high. Average daily volume in the stock is 16 million shares.
...
Click to view a price quote on ARNA.
Click to research the Drugs industry.
if !IE-->endif-->Content on this page requires a newer version of Adobe Flash Player.if !IE-->endif-->
SAN DIEGO (TheStreet) -- Arena Pharmaceuticals' share price and trading volume are sharply higher two weeks in front of an expected U.S. approval decision on the company's weight-loss drug.
Ninety minutes into Wednesday trading, more than 23 million shares of Arena have already traded hands with the stock up 7% to $8.42 -- a five-year high. Average daily volume in the stock is 16 million shares.
...
Click to view a price quote on ARNA.
Click to research the Drugs industry.
Comments